MedPath

The Role of Fitostimoline Proctogel in Symptoms Relief and Healing in Patients Affected by Anal Fissure

Not Applicable
Conditions
Fissure in Ano
Registration Number
NCT04714684
Lead Sponsor
Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia
Brief Summary

Evaluate the effectiveness of fitostimoline proctogel in the anal fissure healing and in the need for invasive interventions (primary endpoints) and in the healing of the fissure (secondary endpoint) using Fitostimoline in addition to or without other topical devices available on the market.

Three groups will be established: one for the exclusive use of fitostimoline, the second for the use of fitostimoline in addition to one of the other topical devices already on the market and the third group only for the use of other topical therapies.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
100
Inclusion Criteria
  • None previous therapies for anal fissure
  • Symptomatic anal fistula
  • Signing of informed consent
  • age >18 years old
Exclusion Criteria
  • Patients unable to complete the questionnaire and with a legal guardian.
  • Patients with concomitant abscess/fistula
  • Pregnant women

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
control of anal fissure symptoms30 days

pain relief (by using the NRS scale from 0 to 10 (0=absence of pain 10= maximum presence of pain) which should be lower than 3)

need of invasive treatment30 days

Anal dilatation, lateral internal sphincterotomy

Secondary Outcome Measures
NameTimeMethod
anal fissure healing30 days

no pain (NRS scale \< 1, where 0 is absence of pain and 10 is maximum pain), no bleeding

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.